Axsome Therapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $28M | 325k | 84.61 |
| 2024-09-30 | $36M | 400k | 89.87 |
| 2024-06-30 | $32M | 400k | 80.50 |
| 2023-06-30 | $24M | 340k | 71.86 |
| 2023-03-31 | $19M | 300k | 61.68 |
| 2022-12-31 | $25M | 325k | 77.13 |
| 2022-06-30 | $7.9M | 205k | 38.30 |
| 2021-03-31 | $11M | 200k | 56.62 |
| 2020-12-31 | $16M | 200k | 81.47 |
| 2020-09-30 | $18M | 250k | 71.25 |
| 2020-06-30 | $29M | 350k | 82.28 |
| 2020-03-31 | $29M | 500k | 58.83 |
| 2019-12-31 | $62M | 600k | 103.36 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management